Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.

Voyle N, Patel H, Folarin A, Newhouse S, Johnston C, Visser PJelle, Dobson RJB, Kiddle SJ, EDAR and DESCRIPA study groups and the Alzheimer’s Disease Neuroimaging Initiative